Abstract Nitric oxide ( • NO) and • NO-derived reactive species (e.g., peroxynitrite anion, nitrogen dioxide radical) react with lipids containing unsaturated fatty acids to generate nitrated species. In the present work, we synthesized, characterized, and detected a nitrated derivative of cholesteryl linoleate (Ch18:2) in human blood plasma and lipoproteins using a high-pressure liquid chromatography coupled to electrospray ionization tandem mass spectrometry method. It was synthesized by a reaction of Ch18:2 with nitronium tetrafluoroborate, yielding a species with m/z 711, which is characteristic of the cholesteryl nitrolinoleate (Ch18:2NO 2 ) ammonium adduct. The presence of the nitro group was confirmed by us- 
Nitric oxide ( • NO) is an endogenously produced free radical that can modulate several relevant biological actions.
• NO is the primary source of several substances with oxidant and nitrating activities [e.g., nitrogen dioxide radical ( • NO 2 ), peroxynitrite anion] ( Reaction 1 ) that can yield nitrated and/or nitrosylated endogenous substances (1, 2) . Nitrated lipid formation was initially described in studies that aimed at modeling acute and chronic exposures of pulmonary lipids to NO 2 in severely polluted urban atmospheres, providing evidence that at low ppm levels, NO 2 reacts with unsaturated fatty acids, leading to nitrolipids formation (3) (4) (5) .
Nitrated lipid formation has also been shown in a variety of in vitro model systems, including unsaturated free fatty acids, phosphatidylcholine liposomes, LDL oxidized by copper, endothelial cells, and macrophages (6) (7) (8) (9) . This formation can be primarily a consequence of • NO or its metabolites reacting with lipid-derived radicals (e.g., L • , LO • , LOO • ) via diffusion-limited rates (10 9 to 10 11 mol/l Ϫ 1 /s Ϫ 1 ) (10, 11) leading to the formation of nitrated products with structural characteristics of nitrolinoleate, nitritelinoleate (LONO), nitratelinoleate (LONO 2 ), L(O)NO 2 , and nitrohydroxylinoleate (12) (13) (14) (15) (16) (17) (18) . Nitrolipids can also be formed by a direct reaction of • NO 2 with nonoxidized lipids at physiological pH (16) , or by a reaction of nitrous acid (HONO) ( Reaction 2 ), a product yielded by nitrite acidification, with oxidized lipids (16, 18) . At physiological pH, e.g., 7.4, NO 2 Ϫ is reasonably stable. However, in an acidic media, as in inflammatory states, gastric compartment, and neutrophil phagocytic vesicles, NO 2 Ϫ equilibrates with HONO ( pK a ϭ 3.25), which, in turn, is readily converted to a range of potent nitrosating/nitrating species, such as • NO 2
and N 2 O 3 , ( Reactions 3 , 4 ) capable of inducing modifications of polyunsaturated fatty acids (18) . Recent studies have demonstrated the presence of these products in biological samples. A vicinal nitrohydroxy arachidonate derivative was detected in bovine coronary arteries, which spontaneously releases • NO, causing relaxation in rat coronary aorta rings (19) . Nitrolinoleate and its nitrohydroxy derivative, nitrohydroxylinoleate, were detected in human blood plasma (20) . Moreover, some studies have demonstrated biological activities of these nitrated products, such as endothelium independent vasorelaxation (19, 21) , inhibition of platelet aggregation (22) , and antinflamatory actions, such as inhibition of superoxide generation, neutrophil degranulation, and integrin expression (23) , suggesting that these nitrated lipids could have vascular-protective effects.
In the present work, for the first time, is reported the presence of cholesteryl nitrolinoleate (Ch18:2NO 2 ), a stable cholesteryl linoleate (Ch18:2)-derived nitrated product, in human blood plasma and lipoproteins, using high-pressure liquid chromatography coupled to electrospray ionization tandem mass spectrometry (LC-ESI/MS/MS). The ex vivo detection of these products represents an important step in the understanding of the protective and/or deleterious effects of in vivo modified lipoproteins on blood vessels. 
MATERIALS AND METHODS

Chemicals
Nitration of Ch18:2
A solution of Ch18:2 (0.07 mmol) in chloroform (2 ml) was purged with nitrogen, and solid NO 2 BF 4 was added (0.12 mmol). The mixture was kept under nitrogen atmosphere at room temperature for 1 h, and then 1 ml of 0.1 M phosphate buffer, pH 7.4 was added. The organic layer was separated, dried, and redissolved in 1 ml of 2-propanol. To isolate the nitrated lipids, the extract was passed through a 2.5 cm ϫ 5.5 cm silica gel (200-400 mesh) column equilibrated with hexane. Nitrated lipids were separated from Ch18:2 with a hexane-diethyl ether step gradient (5% increments from 0 to 20% of diethyl ether). The content of nitrated lipid in the eluted fraction was monitored by thin-layer chromatography (TLC) using a mixture of methanol-chloroform (1:1; v/v) as solvent. Lipid fraction (1 l) was applied to RP-18 F 254s 5 ϫ 10 cm TLC plates (Merck KgaA, Darmstadt, Germany), where the separated lipid components were detected with iodine. Fractions containing mainly nitrated lipids were separated, dried under a vacuum, redissolved in 2-propanol, maintained at Ϫ 20 Њ C, and analyzed by LC-ESI/MS/MS. Nitration was also done by adding sodium 
Structural and quantitative analyses of nitrated lipids by LC-ESI/MS/MS and infrared spectroscopy
Mass spectrometry analysis was performed on a Quattro II triple quadrupole mass spectrometer (Micromass, Manchester, UK) following reversed-phase HPLC on a 20 ϫ 4.0 mm id, 4 , Mercury MS column (Phenomenex, Torrance, CA) using an isocratic system with methanol-tert -butanol (3:1; v/v) containing 10 mM of ammonium acetate as mobile phase at a flow rate of 0.4 ml/min. The column eluent was totally inserted into the ion spray interface. Positive ion mass spectra were recorded with an orifice potential of 20 V. The source temperature was kept at 100 Њ C. Daughter ion and multiple reaction monitoring (MRM) mass spectra were obtained with a collision energy of 10 eV or 20 eV, respectively, and gas (Ar) pressure at 6.0 ϫ 10 Ϫ 4 mbar. The full scan was made at an interval between m/z 40 and 800. The nitrated product was detected in MRM mode as ammonium adduct [M ϩ NH 4 ] ϩ , selecting the ions of m/z 711 in the first and 369 in the third quadrupole ( m/z 711 →369). The MRM transition for Ch18:2 and 3 H-labeled cholesteryl linoleate ( 3 H-Ch18:2) were also measured as m/z 666→369 and m/z 668→371, respectively. This detection mode was used to increase the specificity of the analysis. Quantitative yields of nitrated product (Ch18:2NO 2 ) were calculated by elemental analysis of nitrogen content using a chemiluminescent nitrogen detector (Sievers ® NOA 280, Boulder, CO) using sodium nitrite as standard. The data obtained for Ch18:2NO 2 were used for its quantification in the LC-ESI/MS/MS system. A calibration curve was also performed with Ch18:2. The lipid residue obtained after treatment of Ch18:2 with NO 2 BF 4 was used for infrared (IR) analysis. IR spectra were obtained with a Bomem MB 100 spectrometer by accumulating 32 scans between 400 and 4,000 cm Ϫ1 .
LDL isolation and lipid extraction
Human blood from four normolipidemic subjects (cholesterol Ͻ200 mg/dl) was collected after overnight fasting in tubes containing ethyldiaminetetraacetic acid (EDTA). Plasma was obtained after blood centrifugation at 2,500 rpm for 10 min at 4ЊC, and antiprotease inhibitors and antioxidants were immediately added to avoid lipoprotein degradation. Lipoproteins were separated from plasma by sequential ultracentrifugation using a Sorvall ® Ultra Pro 80 (Sorvall Products L.P., Newtown, CT) and dialyzed against Tris buffer, pH 7.4, (150 mM NaCl, 1.0 mM EDTA, 3 mM NaN 3, and 10 mM Tris) for 12 h. Lipid extraction from VLDL, LDL, and/or HDL was done by mixing 1 ml of each lipoprotein fraction with 500 l of methanol, with vortex stirring for 30 s. Then 5 ml of hexane-diethyl ether (80:20; v/v) containing 0.02% butylated hydroxytoluene, previously treated with Chelex ® to avoid further lipid oxidation during lipid extraction, was added. Samples were vortexed (2 min) and centrifuged at 2,500 rpm for 5 min at 4ЊC. The upper layer was collected, filtered (0.22 ), and evaporated to dryness in a vacuum rotary evaporator. Lipids were dissolved in 100 l of tert-butanol-methanol (1:1; v/v), and then 10 l was immediately injected into a LC-ESI/MS/MS system using the protocol described for the standards. The same extraction system was used in the blood plasma analyses. To verify a possible artifactual nitration of Ch18:2 during the handling of the samples, the extraction procedure was also performed by the addition of an internal standard 3 H-labeled Ch18:2 in plasma (100 pmol in chloroform), which can also be followed by LC-ESI/MS/MS.
RESULTS
LC-ESI/MS/MS and IR spectroscopic analyses of Ch18:2 nitration
When Ch18:2 reacted with NO 2 BF 4 , the main reaction products, eluting at 5.9 min, were ions with m/z 711 (Fig. 1A) (Fig. 1B) . The presence of a ϪNO 2 group on the ion with m/z 711 was confirmed by synthesizing Ch18:2NO 2 by reacting Na 15 NO 2 with Ch18:2. This reaction yielded a molecular ion of m/z 712 that fragments given a main ion of m/z 369, which showed the same isotopic abundance pattern of those of m/z 711→369 ion (Fig. 2) . The Ch18:2 used in the synthesis yielded ‫%07ف‬ of Ch18:2NO 2 .
The IR spectrum of the compound with m/z 711 showed a characteristic absorption of a nitro group directly attached to the carbon chain (1,549 cm Ϫ1 and 1,374 cm Ϫ1 , Fig. 3) . No bands occurred in the 1,600-1,680 cm Ϫ1 region where the N ϭ O binding of a LONO or LONO 2 strongly absorbs.
Determination of nitrated products in plasma and lipoproteins
When human blood plasma and LDL samples were analyzed by the same LC-ESI/MS/MS method used for synthesized standards, a major product having an ion of m/z 711→369 was found. Moreover, the m/z 711 ion showed a fragmentation pattern and retention time identical to those of products synthesized by the reaction of Ch18:2 with NO 2 BF 4 or NO 2 Ϫ in acid pH [ Fig. 4A (trace a) , B]. The product with m/z 711 that fragments in m/z 369 was detected in LDL (Fig. 5) , as well as in VLDL and HDL samples (data not shown). The addition of [ 3 H]-Ch18:2 to samples before the extraction procedure did not yield the (Fig. 6A, B) . The [ 3 H]-Ch18:2 added to plasma samples, which has the same retention time as Ch18:2 (Fig.  6C) , appears as a molecular ion of m/z 668 [MϩNH 4 ] ϩ , which fragments given a main ion of m/z 371 (Fig. 6D) (Fig. 7) . The concentrations observed in plasma samples (mean Ϯ SD, n ϭ 4) were 76.9 Ϯ 10.7 (nmol/l) and 30 Ϯ 8.7 (mol/l) for Ch18:2NO 2 and Ch18:2, respectively.
DISCUSSION
The reaction of Ch18:2 with NO 2 BF 4 yielded a main product that exhibited a molecular ion with m/z 711, when analyzed by LC-ESI/MS/MS, characteristic of a nitrated Ch18:2 ammonium adduct. The MS/MS fragmen- (24), indicating that nitration was occurring in the carbon chain instead of the cholesterol ring. The same product was obtained when Ch18:2 was treated with aqueous acidic sodium nitrite under aerobic conditions. The synthesis with NO 2 BF 4 was chosen for IR and LC-ESI/MS/MS experiments due to a higher yielding of the nitrated Ch18:2 product when compared with the synthesis performed with nitrite. The nitration mechanisms for these synthesis procedures must be different (12, 13) . When NO 2 BF 4 is used, the nitration occurs by nitronium ion (NO 2 ϩ ) addition in the double bond on the carbon chain (Fig. 8) . In the reaction with sodium nitrite under acidic and aerobic conditions, the nitration occurs when • NO 2 formed by nitrite acidification in the presence of oxygen abstracts an H atom from the allylic position of the fatty acid, forming a resonance-stabilized radical. This radical further reacts with another • NO 2 molecule, forming a nitrolipid derivative (Fig. 8) . In vivo, lipid nitration probably occurs by a radical-mediated mechanism in which • NO 2 is generated by peroxidase-dependent oxidation of nitrite (25) . The • NO 2 can also be formed by other biological systems, such as in inflammatory states, gastric compartment, and neutrophil phagocytic vesicles (18) .
The characterization of nitration by mass spectrometry was performed by reacting Ch18:2 with [ 15 N]nitrite, in acidic media, obtaining a main ion with m/z 712, which showed the same fragmentation and isotopic abundance patterns of those of m/z 711 ions. The isotopic abundance pattern confirms that the spectra obtained are relative to compounds containing ‫05ف‬ carbons, such as Ch18:2 (26). The increase of one mass unit using [ 15 N]nitrite confirms that the ion contains one nitrogen atom per molecule and is compatible with the nitrated Ch18:2 structure. This evidence was reinforced by IR analyses of the nitrated product, as compared with Ch18:2, that showed novel bands at 1,549 and 1,373 cm Ϫ1 , corresponding to the N ϭ O binding of RNO 2 (27) . These results clearly showed that the product formed in this synthesis is Ch18:2NO 2 . It was not possible to determine the position of the nitro group in the carbon chain of the fatty acid. It is possible that a mixture of stereo and positional isomers (i.e., at C 9 , C 10 , C 12 , or C 13 and/or cis-trans isomers) is formed that is not possible to discriminate by mass spectrometry analysis.
The analysis of blood plasma and lipoproteins showed an ion with m/z 666, characteristic of the Ch18:2 ammonium adduct, as previously described (28) . Ch18:2 was chosen because it is the predominant lipid component in the LDL core (28) and linoleic acid (18:2) is the most abundant polyunsaturated fatty acid in human blood plasma (29) . As the presence of double-bonded carbons is an initial condition for • NO 2 attack (18), polyunsaturated fatty acids would be suitable substrates for • NO 2 -mediated nitration. Fragmentation of the ion with m/z 666 showed a main daughter ion with m/z 369, characteristic of the cholesteryl group, as previously described (28) .
Products given molecular ions with m/z 711, showing the same chromatographic characteristics and fragmentation pattern as those of synthesized standards, were found in human blood plasma and lipoproteins of normolipidemic donors. A possible artifactual nitration that could occur during the extraction procedure was tested by adding [ 3 H]-labeled Ch18:2 to plasma samples. As the corresponding nitrated [ 3 H]-Ch18:2 was not detected, an artifactual nitration during sample workup was excluded. The possibility that azide contributes to nitration was also excluded, because azide was used only for isolation of lipoproteins and not for plasma samples. Small differences in MS/MS fragmentation spectra patterns between synthe- sized standards and products of plasma or lipoproteins could be explained by the presence of different positional isomers and/or functional group orientation (e.g., ϪNO 2 or ϪONO) in vivo. Furthermore, the possibility cannot be excluded that Ch18:2-ONO (cholesteryl nitritelinoleate) could be formed in vivo and decomposed by transnitrozation or other routes during sample extraction and workup.
Nitrated lipids present in plasma and lipoproteins can be considered as potential indicators of the chain-breaking antioxidant role of • NO during lipid peroxidation, as previously reported (7, 8, 11) , indicating that reactions of • NO, or its derivatives, with lipids may be important in vivo. Due to its relative hydrophobicity, • NO readily diffuses into hydrophobic lipid membranes, greatly increasing its local concentration (30) . This property significantly increases the chainbreaking efficiency of low concentrations of • NO, favoring lipid peroxidation inhibition. Nitrated lipids could also be formed in vivo in the lipid microenvironments where the rate of • NO autoxidation is high (e.g., with concurrent • NO and O 2 therapy during lung disease) or where high NO 2 Ϫ concentrations are combined with low pH (e.g., gastric compartment, phagolysosome, and ischemic events) (16, 18) .
In the context of hypercholesterolemia, we recently described increased levels of nitrated linoleic acid derivatives in plasma of hyperlipidemic compared with normolipidemic subjects (20) . These could be implicated in the formation of reactive nitrogen species during plasma and/or tissue oxidative damage in hyperlipidemia. In fact, enhancement of • NO production during hypercholesterolemia has been associated with low • NO bioactivity (31) (32) (33) (34) (35) (36) . It is also well known that the increase of oxidative stress in hypercholesterolemia (37) (38) (39) implicated in the generation of reactive oxygen species could contribute to the formation of nitrated species in the vascular wall. Therefore, the presence of nitrated lipids in plasma can be an indicator of the inhibitory role of • NO in lipid oxidation, and/or a footprint of the presence of oxidants/nitrating agents in the vascular system. Finally, whereas it is suggested that these nitrated lipids cause vasorelaxation by • NO release (19, 21) and have other beneficial effects in the atherothrombotic process, such as inhibition of platelet aggregation and antiinflamatory actions (22, 23) , we postulate that the presence of these nitrated products in vivo would indicate primarily a storage form of • NO acting as a compensatory mechanism for the impaired endothelial-dependent vasorelaxation characteristic of the early steps of vascular disease. 
